Want to see AU:REG full AI Analyst Report?
Top Page
Regis Healthcare Ltd.
(Sydney:REG)
Select Model
Select Model
Rating:53Neutral
Price Target:
AU$4.50
▼(-26.83% Downside)
Action:Reiterated
Date:08/26/26
The score is anchored by improving financial performance—especially strong cash generation and a multi-year recovery in revenue and profitability—but is constrained by negative equity and thin/variable margins. Technicals are also a headwind with the stock trading below key moving averages, and valuation is only middling due to a relatively high P/E despite a moderate dividend yield.
Positive Factors
Strong revenue and profit recovery
Sustained revenue growth and a durable return to profitability indicate improving operating performance and service demand. Continued top-line expansion can support reinvestment, while positive earnings provide a stronger base for funding aged care operations and future growth.
Negative Factors
Negative shareholders' equity
Persistent negative shareholders’ equity indicates a thin capital cushion despite the company’s low debt position. This reduces financial flexibility, leaves less balance-sheet protection against operating setbacks, and may constrain the ability to absorb future losses or fund expansion internally.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue and profit recovery
Sustained revenue growth and a durable return to profitability indicate improving operating performance and service demand. Continued top-line expansion can support reinvestment, while positive earnings provide a stronger base for funding aged care operations and future growth.
Read all positive factors
Regis Healthcare Ltd. (REG) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$1.33B
Dividend Yield4.19%
Average Volume (3M)1.36M
Price to Earnings (P/E)23.8
Beta (1Y)0.90
Revenue Growth16.55%
EPS Growth13.42%
CountryAU
Employees13,000
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.18
Shares Outstanding302,464,420
10 Day Avg. Volume1,135,582
30 Day Avg. Volume1,360,152
Financial Highlights & Ratios
PEG Ratio2.88
Price to Book (P/B)-161.60
Price to Sales (P/S)1.46
P/FCF Ratio10.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$6.08Price Target Upside-1.22% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)0.19
Revenue Forecast (FY)AU$1.46B
Regis Healthcare Ltd. Business Overview & Revenue Model
Company Description
Regis Healthcare Limited is a leading Australian provider specializing in comprehensive care services for the elderly. The company operates a network of residential aged care facilities and delivers a broad spectrum of in-home support. These home-...
How the Company Makes Money
Regis Healthcare makes money primarily by delivering aged care services across three main channels: (1) Residential aged care: The company earns revenue from operating aged care homes, which typically includes a combination of Australian Governmen...
Regis Healthcare Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
34
Negative
Cash Flow
74
Positive
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.34B | 1.15B | 1.01B | 771.48M | 717.89M |
| Gross Profit | 152.61M | 141.46M | 47.17M | -3.78M | 5.18M |
| EBITDA | 107.13M | 240.44M | 191.45M | 96.81M | 55.86M |
| Net Income | 55.69M | 48.95M | -21.41M | -28.45M | -38.80M |
Balance Sheet | |||||
| Total Assets | 2.60B | 2.11B | 1.81B | 1.71B | 1.76B |
| Cash, Cash Equivalents and Short-Term Investments | 173.77M | 192.47M | 64.91M | 61.32M | 4.15M |
| Total Debt | 3.99M | 5.11M | 3.84M | 71.07M | 113.32M |
| Total Liabilities | 2.61B | 2.12B | 1.84B | 1.67B | 1.68B |
| Stockholders Equity | -12.13M | -16.72M | -22.89M | 38.39M | 79.01M |
Cash Flow | |||||
| Free Cash Flow | 194.24M | 219.64M | 186.57M | 53.73M | 67.60M |
| Operating Cash Flow | 336.25M | 306.11M | 252.30M | 105.16M | 114.79M |
| Investing Cash Flow | -301.42M | -132.74M | -136.59M | 6.58M | -48.62M |
| Financing Cash Flow | -53.53M | -45.81M | -112.12M | -43.17M | -62.39M |
Regis Healthcare Ltd. Technical Analysis
Negative
6.15
Price Trends
5.24
Negative
5.70
Negative
6.01
Negative
Market Momentum
-0.24
Negative
36.54
Neutral
38.80
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:REG, the sentiment is Negative. The current price of 6.15 is above the 20-day moving average (MA) of 4.52, above the 50-day MA of 5.24, and above the 200-day MA of 6.01, indicating a bearish trend. The MACD of -0.24 indicates Negative momentum. The RSI at 36.54 is Neutral, neither overbought nor oversold. The STOCH value of 38.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:REG.
Regis Healthcare Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | AU$88.07M | 9.71 | 14.90% | 3.96% | 15.77% | 48.47% | |
63 Neutral | AU$9.22B | 15.16 | 7.20% | 5.79% | 14.40% | 15.11% | |
58 Neutral | AU$12.55B | 40.18 | 6.58% | 1.67% | 4.36% | 4799.64% | |
53 Neutral | AU$1.33B | 23.78 | -264.68% | 4.19% | 16.55% | 13.42% | |
52 Neutral | AU$9.73M | 83.33 | 3.34% | ― | 121.40% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | AU$283.21M | -0.68 | -114.08% | 35.60% | 2.16% | 21.05% |
* Healthcare Sector Average
AU:REG
Regis Healthcare Ltd.
4.39
-1.91
-30.36%
AU:EPN
Epsilon Healthcare Limited
0.03
<0.01
4.17%
AU:HLS
Healius Limited
0.39
-0.38
-49.35%
AU:RHC
Ramsay Health Care
54.64
23.32
74.45%
AU:AHC
Austco Healthcare Limited
0.24
-0.19
-44.05%
AU:SHL
Sonic Healthcare Limited
18.65
-1.34
-6.68%
Regis Healthcare Ltd. Corporate Events
Regis Healthcare Performance Rights Lapse Alters Capital Structure
Sep 18, 2026
Regis Healthcare Ltd has announced the lapse of 186,213 performance rights, which were conditional securities that ceased because their performance conditions were not met or became incapable of being satisfied as of 31 August 2026. The lapse redu...
Regis Healthcare Director Increases Indirect Shareholding
Sep 14, 2026
Regis Healthcare has disclosed changes in the indirect shareholdings of director Ian Gregory Roberts, reflecting an on-market purchase of 54,405 ordinary shares by JNR Capital Pty Ltd as trustee for the JNR Trust. The transaction increases Roberts...
Regis Healthcare Seeks ASX Quotation for New Employee Scheme Shares
Sep 7, 2026
Regis Healthcare Ltd. has applied for quotation on the ASX of 68,543 new ordinary fully paid shares issued on 4 September 2026 under an employee incentive scheme. These securities, to trade under the REG ticker, will be listed following the compan...
Regis Director Hodges Increases Indirect Shareholding via On-Market Purchase
Sep 6, 2026
Regis Healthcare Ltd has disclosed a change in director Graham Kennedy Hodges’ indirect interest in company securities, reflecting an on-market purchase of additional shares. Through the G A Hodges Super Fund account, of which he is a trust...
Regis Healthcare Director Sally Freeman Increases Shareholding
Sep 4, 2026
Regis Healthcare Ltd has reported a change in director Sally Margaret Freeman’s indirect interest in the company’s securities. Freeman acquired 14,318 ordinary shares on-market through accounts held with Netwealth Investments Limited o...
Regis warns AN‑ACC funding lift lags rising aged care costs
Sep 2, 2026
Regis Healthcare Limited has responded to the Australian Government’s decision to lift the Australian National Aged Care Classification starting price by 2.55% to $303.19 per resident per day from 1 October 2026, while leaving the hotelling ...
Regis Healthcare Director Increases Shareholding via On‑Market Trade
Aug 31, 2026
Regis Healthcare Ltd has disclosed a change in the shareholding of director Carmel Anne Monaghan, who increased her direct interest in the company through an on‑market trade. On 28 August 2026, Monaghan purchased 6,430 ordinary shares for $3...
Regis Healthcare Director Boosts Stake with On-Market Share Purchase
Aug 31, 2026
Regis Healthcare has disclosed a change in director Andrew John Kinkade’s interests, with the purchase of 40,000 ordinary shares in the company. The on-market acquisition, valued at about $245,832 before costs, increases Kinkade’s dire...
Regis Healthcare Sets 2026 AGM Date and Director Nomination Deadline
Aug 23, 2026
Regis Healthcare has scheduled its 2026 Annual General Meeting for Tuesday, 17 November, at 10:00am AEDT, with detailed participation instructions to be issued in the forthcoming Notice of Meeting. The company has also set 14 September 2026 as the...
Regis Healthcare Files Updated ASX Corporate Governance Statement
Aug 23, 2026
Regis Healthcare Limited has lodged its corporate governance statement for the year ended 30 June 2026 with the ASX, confirming that the document is current as of 21 August 2026 and available on its website. The statement outlines how the company ...
Regis Healthcare Delivers Strong FY26 Results and Expands Aged Care Portfolio
Aug 23, 2026
Regis Healthcare reported a strong FY26, with revenue from services rising 16% to $1.35 billion and underlying EBITDA up 10% to $138 million, while statutory profit increased 14% to $55.7 million. Net operating cash flow climbed to $336.3 million,...
Regis Healthcare appoints new CFO to drive next growth phase
Aug 23, 2026
Regis Healthcare has appointed experienced finance executive Stuart Hooper as its new Chief Financial Officer, effective 1 September 2026, succeeding outgoing CFO Rick Rostolis. Hooper brings extensive healthcare, infrastructure and corporate fina...
Regis Healthcare to acquire Royal Freemasons’ Victorian home care business
Aug 2, 2026
Regis Healthcare has entered a binding agreement to acquire Royal Freemasons Homes of Victoria’s home care business, adding around 480 clients and expanding its presence in Melbourne. The deal, funded from existing cash and subject to regula...
Regis Healthcare CFO Rick Rostolis to Retire After Guiding Growth and M&A Strategy
Jul 12, 2026
Regis Healthcare has announced the retirement of Chief Financial Officer Rick Rostolis, whose four-decade executive career included key ASX-listed CEO and CFO roles. Since joining Regis, Rostolis has strengthened the company’s financial posi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.